skip to main content


Sagard Healthcare

Sagard Healthcare invests in royalties and credit backed by approved and commercialized biopharmaceutical products, diagnostics and medical devices. We aim to accelerate the returns on innovation for owners of intellectual property while offering investors an attractive healthcare exposure largely uncorrelated to other asset classes. Sagard Healthcare is led by a team that has worked together for over a decade.

Flowing river.

Investment approach and value proposition

Our differentiation

  • We are a proven team of industry experts with deep experience in a complex investment strategy and a history of working together
  • We have a flexible mandate including royalty monetization, revenue-interest financing and traditional credit to match the right type of investment to each opportunity, and direct capital to areas of higher relative value
  • Our focus on the long-term enables value maximization for both sides in a transaction
  • As part of the Sagard platform, we have access to strong operational infrastructure, business support, and networks, enabling our team to focus on investments that accelerate returns on innovation in the healthcare industry

Investment criteria

  • We acquire royalties, provide royalty-backed loans and invest directly in approved biopharmaceuticals, diagnostics and medical devices in return for a royalty on direct sales
  • Typical investment size between $25M and $150M
    • We can do smaller transactions to support innovative emerging companies
    • Through our LP co-investment program, we can do larger deals in the hundreds of millions

Our portfolio companies

We partner with ambitious companies to help them achieve their aspirations.

See all companies

The Sagard team

Meet the team
About us

About Sagard

Learn more

Connect with us

Get in touch
Back To Top